| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 396 | 2013 |
| Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B/H4 acetylation-dependent … O Bousiges, AP Vasconcelos, R Neidl, B Cosquer, K Herbeaux, ... Neuropsychopharmacology 35 (13), 2521-2537, 2010 | 190 | 2010 |
| A novel activator of CBP/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice S Chatterjee, P Mizar, R Cassel, R Neidl, BR Selvi, DV Mohankrishna, ... Journal of Neuroscience 33 (26), 10698-10712, 2013 | 160 | 2013 |
| Acetyltransferases (HATs) as targets for neurological therapeutics A Schneider, S Chatterjee, O Bousiges, BR Selvi, A Swaminathan, ... Neurotherapeutics 10 (4), 568-588, 2013 | 122 | 2013 |
| Epileptic prodromal Alzheimer’s disease, a retrospective study of 13 new cases: expanding the spectrum of Alzheimer’s disease to an epileptic variant? B Cretin, F Sellal, N Philippi, O Bousiges, L Di Bitonto, C Martin-Hunyadi, ... Journal of Alzheimer's Disease 52 (3), 1125-1133, 2016 | 108 | 2016 |
| Late-life environmental enrichment induces acetylation events and nuclear factor κB-dependent regulations in the hippocampus of aged rats showing improved plasticity and learning R Neidl, A Schneider, O Bousiges, M Majchrzak, A Barbelivien, ... Journal of Neuroscience 36 (15), 4351-4361, 2016 | 87 | 2016 |
| GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study A Rongve, A Witoelar, A Ruiz, L Athanasiu, C Abdelnour, J Clarimon, ... Scientific reports 9 (1), 7013, 2019 | 72 | 2019 |
| Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator S Chatterjee, R Cassel, A Schneider‐Anthony, K Merienne, B Cosquer, ... EMBO Molecular Medicine 10 (11), e8587, 2018 | 71 | 2018 |
| Detection of histone acetylation levels in the dorsal hippocampus reveals early tagging on specific residues of H2B and H4 histones in response to learning O Bousiges, R Neidl, M Majchrzak, MA Muller, A Barbelivien, ... PloS one 8 (3), e57816, 2013 | 68 | 2013 |
| Dysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer's disease patients E Schueller, I Paiva, F Blanc, XL Wang, JC Cassel, AL Boutillier, ... European neuropsychopharmacology 33, 101-116, 2020 | 62 | 2020 |
| A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles S Lehmann, J Dumurgier, S Schraen, D Wallon, F Blanc, E Magnin, ... Alzheimer's research & therapy 6, 1-9, 2014 | 59 | 2014 |
| Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases A Echaniz-Laguna, O Bousiges, JP Loeffler, AL Boutillier Current medicinal chemistry 15 (13), 1263-1273, 2008 | 50 | 2008 |
| Diagnostic value of cerebrospinal fluid biomarkers (Phospho-Tau 181, total-Tau, Aβ 42, and Aβ 40) in prodromal stage of Alzheimer’s disease and dementia with Lewy bodies O Bousiges, B Cretin, T Lavaux, N Philippi, B Jung, S Hezard, C Heitz, ... Journal of Alzheimer's Disease 51 (4), 1069-1083, 2016 | 48 | 2016 |
| Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer’s disease at the prodromal stage O Bousiges, S Bombois, S Schraen, D Wallon, MM Quillard, A Gabelle, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (5), 467-475, 2018 | 42 | 2018 |
| Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview C Delaby, CE Teunissen, K Blennow, D Alcolea, I Arisi, EB Amar, ... Alzheimer's & Dementia 18 (10), 1868-1879, 2022 | 36 | 2022 |
| Do we know how to diagnose epilepsy early in Alzheimer's disease? B Cretin, N Philippi, O Bousiges, L Dibitonto, F Sellal, C Martin-Hunyadi, ... Revue neurologique 173 (6), 374-380, 2017 | 35 | 2017 |
| The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies C Abdelnour, D Ferreira, K Oppedal, L Cavallin, O Bousiges, LO Wahlund, ... NeuroImage: Clinical 27, 102333, 2020 | 29 | 2020 |
| Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort F Blanc, V Bouteloup, C Paquet, M Chupin, F Pasquier, A Gabelle, ... Alzheimer's research & therapy 14 (1), 96, 2022 | 24 | 2022 |
| Environmental exposure to phthalates and dementia with Lewy bodies: contribution of metabolomics A Agin, F Blanc, O Bousiges, C Villette, N Philippi, C Demuynck, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (9), 968-974, 2020 | 22 | 2020 |
| Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage O Bousiges, N Philippi, T Lavaux, A Perret-Liaudet, I Lachmann, ... Alzheimer's Research & Therapy 12, 1-12, 2020 | 20 | 2020 |
Frederic BlancPr. MD-PhD HdR, CM2R, pôle de Gériatrie, Unistra, ICube,CNRS, Hôpitaux Universitaires de Strasbourg在 unistra.fr 的电子邮件经过验证
